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Abstract
The bone morphogenetic proteins (BMPs) play crucial roles in chondrogenic differentiation. Little is known, however,
regarding the regulation of BMP gene expression. Here we examined the effect of parathyroid hormone-related peptide
(PTHrP) (1^141), a full-length form of PTHrP molecules, on the expression of BMP-4 mRNA in clonal mouse chondrogenic
EC cells, ATDC5. In differentiated ATDC5 cells, the expression of BMP-4 mRNA was inhibited by PTHrP (1^141), which
stimulated cAMP accumulation and protein kinase A (PKA) activity in these cells. Dibutyryl cAMP, a permeable analog of
cAMP, mimicked and H-89, a selective PKA inhibitor, blocked this effect of PTHrP (1^141). Moreover, actinomycin D
attenuated the inhibition of BMP-4 mRNA expression by PTHrP (1^141). These results indicate that PTHrP (1^141)
transcriptionally inhibits the expression of BMP-4 mRNA through a cAMP/PKA pathway in ATDC5 cells. ß 2000
Elsevier Science B.V. All rights reserved.
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1. Introduction
The bone morphogenetic proteins (BMPs) were
originally identi¢ed based on their osteoinductive ac-
tivities. When implanted into subcutaneous or mus-
cular tissues of rodents, the BMPs induce ectopic
bone formation through sequential processes of en-
dochondral ossi¢cation [1,2]. Accumulating evidence
indicates that BMP-4 and BMP-6 are expressed in
the cartilage of developing bones and that they func-
tion as potent stimulators of chondrogenic di¡eren-
tiation in vitro and in vivo [3^7]. In contrast, para-
thyroid hormone-related peptide (PTHrP) is a potent
inhibitor of chondrogenic di¡erentiation of chondro-
cytes [8^15]. Previous studies showed that targeted
overexpression of either PTHrP or PTHrP receptor
(R) inhibited chondrogenic di¡erentiation in vitro [9]
and in vivo [14,15] and that homozygous mice carry-
ing either PTHrP or PTHrP-R null mutation each
exhibited widespread abnormalities of cartilage de-
velopment [8,10,11]. However, the interrelationship
between BMPs and PTHrP during chondrogenic dif-
ferentiation remains to be elucidated.
Clonal mouse chondrogenic embryonal carcinoma
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(EC) cells, ATDC5, keep track of the multistep chon-
drogenic di¡erentiation processes in vitro [16^22].
Di¡erentiated ATDC5 cells express PTHrP-R and
BMP-4 [21], both of which coordinately modulate
the processes of chondrogenic di¡erentiation in these
cells. In this study, we indicate that PTHrP (1^141)
transcriptionally downregulates the expression of
BMP-4 mRNA through a cAMP/protein kinase A
(PKA) pathway in ATDC5 cells.
2. Materials and methods
2.1. Materials
Human recombinant PTHrP (1^141) was a kind
gift from Dr. T.J. Martin (St. Vincent’s Institute of
Medical Research, Victoria, Australia), and N6,2P-O-
dibutyryl cyclic AMP (dbcAMP), N-[2-(p-bromo-
cinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-
89), phorbol 12-myristate 13-acetate (PMA), and ac-
tinomycin D were purchased from Sigma Chemical
Co. (St. Louis, MO, USA).
2.2. Cells and culture conditions
ATDC5 cells were cultured as previously described
[17^21]. Brie£y, cells were maintained in a log growth
phase in DMEM/Ham’s F12 hybrid medium (ICN
Pharmaceuticals, Inc., Costa Mesa, CA, USA) con-
taining 5% (v/v) fetal bovine serum (Gibco BRL,
Gaithersburg, MD, USA), 10 mM human transferrin
(Boehringer Mannheim GmbH, Mannheim, Ger-
many), and 30 nM sodium selenite (Sigma Chemical
Co.) (maintenance medium) at 37‡C in a humidi¢ed
5% CO2/95% air atmosphere. Chondrogenesis and
cartilage nodule formation could be induced only
in the postcon£uent phase when cells were cultured
in the maintenance medium supplemented further
with 10 mM bovine insulin (Wako Pure Chemical,
Osaka, Japan) (di¡erentiation medium). In the
present study, we plated ATDC5 cells in 6- or 24-
multiwell plastic plates at an initial density of 6U104
or 2U104 cells/well respectively and cultured these
cells for a total of 23 days with medium replacement
every other day. Cells were cultured for an initial
21-day period in the di¡erentiation medium in a
5% CO2/95% air atmosphere and then cells were
treated for the indicated time periods with various
doses of the test substances in the absence of insulin.
2.3. RNA extraction and Northern analysis
Total RNA was prepared from the cultures as pre-
viously described [17^21]. For Northern hybridiza-
tion, total RNA (20 Wg) was denatured, separated
by 1% agarose gel electrophoresis, and transferred
on Nytran membranes (Schleicher and Schuell, Das-
sel, Germany). Hybridization probes were prepared
by the random-primer method with a BcaBEST la-
beling kit (Takara, Ohtsu, Japan). A 0.6-kb fragment
of BMP-4 mRNA was used as the hybridization
probe. After hybridization, the membranes were ex-
posed to BioMax ¢lms (Eastman Kodak, Rochester,
NY, USA) at 380‡C with Cronex lightening plus
intensifying screens (DuPont, Boston, MA, USA).
The quantitation of hybridization signals was per-
formed by scanning densitometry with a Model 301
Densitometer (Fuji X-Ray, Tokyo, Japan).
2.4. Measurement of cAMP accumulation
E¡ects of PTHrP (1^141) on cAMP accumulation
were assessed as described previously [23]. In brief,
cells were cultured for 21 days in 24-multiwell plates
under the conditions described above. Before experi-
ments, cells were rinsed once with bu¡er containing
Hanks’ medium, 20 mM HEPES (pH 7.5; 22‡C), and
0.1% (w/v) heat-inactivated bovine serum albumin,
then incubated for 30 min at room temperature in
the above bu¡er further containing 0.5 mM 3-isobu-
tyl-1-methylxanthine (Sigma Chemical Co.) and
PTHrP (1^141) (10 nM) or its vehicle. The reaction
was terminated by the addition of ice-cold HCl (¢nal
HCl concentration, 0.1 N). The samples were boiled
(100‡C; 2.5 min) to extract cAMP and diluted with
distilled water and then, the cAMP content in both
cells and medium was measured by a radioimmuno-
assay.
2.5. Measurement of PKA activity
E¡ects of PTHrP (1^141) on PKA activity were
assessed by the methods of Tamanini et al. [24] and
Lee et al. [25]. In brief, cells were cultured for 21 days
in 24-multiwell plates under the conditions described
BBAMCR 14645 6-7-00
H. Ito et al. / Biochimica et Biophysica Acta 1497 (2000) 237^243238
above and then exposed to PTHrP (1^141) (10 nM)
or their vehicle for 3 h at 37‡C. Cells were rinsed
with PBS, extracted with extraction bu¡er (5 mM
EDTA, 50 mM Tris, pH 7.5), and homogenized. Ki-
nase activity in 10 Wg of extracted protein was as-
sessed after incubation for 20 min at 30‡C in the
bu¡er containing 10 mM HEPES at pH 7.0, 10
mM MgCl2, 100 mM ATP, 100 mM dithiothreitol,
0.1 mM [Q-32P]ATP (30 mCi/nmol), and 100 mM
kemptide, followed by termination of the reaction
by the addition of 100 Wl of ice-cold 60% acetic
acid. The reaction mixture was applied to a Dowex
1X8-100 anion exchanger column. Phosphorylated
kemptide was then eluted with 0.8 ml of 30% acetic
acid and the radioactivity was quantitated by a liquid
scintillation counter.
2.6. Statistical analysis
Statistical signi¢cance was assessed by one-way
analysis of variance and unpaired Student’s t-test.
3. Results
3.1. PTHrP (1^141) downregulates the expression of
BMP-4 mRNA in di¡erentiated ATDC5 cells
In the presence of insulin, ATDC5 cells form car-
tilaginous nodules through a cellular condensation
stage. The process proceeded in an orderly and syn-
chronous manner as evidenced by the expression of
phenotypic marker genes with cartilage characteris-
tics as previously reported [17,21]. We recently
showed that BMP-4 was stimulatory and PTHrP
(1^141) was inhibitory to chondrogenic di¡erentia-
tion in di¡erentiated ATDC5 cells [21]. These obser-
vations raise the possibility that PTHrP (1^141) may
regulate BMP-4 gene expression. As shown in Fig. 1,
the steady-state levels of BMP-4 transcript were in-
deed downregulated by PTHrP (1^141) treatment:
PTHrP (1^141) (10 nM) markedly downregulated
the BMP-4 transcript and maximal inhibition oc-
curred 12 h after PTHrP (1^141) treatment.
Fig. 1. E¡ect of exogenously administered PTHrP (1^141) on BMP-4 gene expression in di¡erentiated ATDC5 cells. ATDC5 cells cul-
tured on plastic plates for 21 days were exposed to 10 nM of PTHrP (1^141) for the indicated time periods (time dependence), and to
either vehicle or PTHrP (1^141) (0, 0.1, 1, 10 and 100 nM) for an additional 12 h (dose dependence). Northern analysis was per-
formed using total RNA (20 Wg per lane). The integrity and equal loading of RNA were con¢rmed by ethidium bromide staining.
The results shown are representative of three independent experiments.
Table 1
E¡ects of PTHrP (1^141) on cAMP accumulation and PKA activity in di¡erentiated ATDC5 cells
Control PTHrP 10 nM
cAMP accumulation (pmol/Wg DNA/30 min) 0.095 þ 0.0063 11.1 þ 0.68*
PKA activity (% of control) 100 þ 7.5 121 þ 3.0*
ATDC5 cells cultured on plastic plates for 21 days were exposed to PTHrP (1^141) (10 nM) or its vehicle for indicated time periods.
cAMP accumulation and PKA activity were assessed as described in Section 2. Data are shown as the mean þ S.D. of six separate de-
terminations. Experiments were performed three times with similar results.
*P6 0.01, statistically signi¢cant di¡erence from the corresponding control groups.
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3.2. PTHrP (1^141) stimulates cAMP accumulation
and PKA activity in di¡erentiated ATDC5 cells
PTHrP is a known stimulator of intracellular pro-
duction of cAMP via its binding to PTH/PTHrP cell
surface receptors. In di¡erentiated ATDC5 cells,
1 mM of dbcAMP stimulated PKA activity (1.7-
fold stimulation over the control, data not shown)
and 10 nM of PTHrP (1^141) also caused signi¢cant
stimulation of cAMP accumulation and PKA activ-
ity (117- and 1.2-fold stimulation over the controls,
respectively) (Table 1).
3.3. dbcAMP downregulates the expression of BMP-4
mRNA in di¡erentiated ATDC5 cells
In di¡erentiated ATDC5 cells, PTHrP (1^141)
caused signi¢cant stimulation of cAMP accumula-
tion and PKA activity. We next examined the possi-
bility if a cAMP/PKA pathway mediated the inhibi-
tion of BMP-4 expression by PTHrP (1^141). As
shown in Fig. 2, direct stimulation of PKA activity
by 0.4 mM of dbcAMP, a cell membrane-permeable
analog of cAMP, resulted in transient and marked
inhibition of BMP-4 gene expression in di¡erentiated
ATDC5 cells, compared with the e¡ect of PTHrP (1^
141) treatment. Additionally, retreatment with
0.4 mM of dbcAMP or 10 nM of PTHrP (1^141)
12 h after the initial treatment resulted in continued
inhibition of BMP-4 gene expression for the subse-
quent 12 h (data not shown).
3.4. H-89 blocks the inhibitory action by
PTHrP (1^141) on BMP-4 mRNA expression
To con¢rm that the inhibitory action of PTHrP
(1^141) is mediated via a cAMP/PKA pathway, we
Fig. 2. E¡ect of dbcAMP on BMP-4 gene expression in di¡erentiated ATDC5 cells. ATDC5 cells cultured on plastic plates for 21
days were exposed to 0.4 mM of dbcAMP for the indicated time periods (time dependence), and to either vehicle or dbcAMP (0.1,
0.3, 0.6, and 1 mM) for an additional 12 h (dose dependence). Northern analysis was performed using total RNA (20 Wg per lane).
The integrity and equal loading of RNA were con¢rmed by ethidium bromide staining. The results shown are representative of three
independent experiments.
Fig. 3. Blocking of the inhibitory e¡ect of PTHrP (1^141) on
BMP-4 gene expression by H-89, a PKA inhibitor, in di¡erenti-
ated ATDC5 cells. ATDC5 cells cultured on plastic plates for
21 days were treated for an additional 12 h with a submaximal
dose of PTHrP (1^141) (10 nM), either alone or in the presence
of varying doses of H-89 (1, 10, and 30 WM). Northern analysis
was performed using total RNA (20 Wg per lane). The integrity
and equal loading of RNA were con¢rmed by ethidium bro-
mide staining. The results shown are representative of two inde-
pendent experiments.
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examined the e¡ect of H-89, a selective PKA inhib-
itor, on the inhibitory action of PTHrP (1^141) on
BMP-4 gene expression. As shown in Fig. 3, the
action of PTHrP (1^141) was blocked by H-89 in a
dose-dependent manner. Treatment with H-89 alone
did not a¡ect the steady-state levels of BMP-4 tran-
script (data not shown).
3.5. The inhibitory action by PTHrP (1^141) on the
expression of BMP-4 in di¡erentiated ATDC5
cells is attenuated by actinomycin D
cAMP/PKA signaling directly regulates the gene
transcripts via the cAMP responsive element binding
protein and the cAMP responsive element modulator
which bind cAMP responsive elements in the pro-
moter region of cAMP responsive genes. We hy-
pothesized that PTHrP (1^141) transcriptionally
regulated the levels of BMP-4 gene transcript in dif-
ferentiated ATDC5 cells. In Fig. 4, it is shown that
pretreatment of ATDC5 cells with actinomycin D, a
transcriptional inhibitor, signi¢cantly attenuated the
e¡ect of PTHrP (1^141) on the inhibition of BMP-4
gene expression.
4. Discussion
The BMP family plays a vital role in skeletal de-
velopment, and several BMP family genes are ex-
pressed at sites of bone formation with a unique
spatiotemporal pattern, suggesting that the coordi-
nated expression of these molecules is crucial for
the cascade of events underlying chondrogenic di¡er-
entiation. Previous studies showed that BMP recep-
tor type IA is essential for proper progression of the
chondrogenic di¡erentiation program in vitro and in
vivo [26,27]. Furthermore, recent in vivo studies in-
dicated that activation of BMP signaling by either
overexpression of the BMP family in chondrocytes
or deletion of a BMP antagonist resulted in deform-
ities of bone rudiments by the acceleration of the
progression of chondrogenic di¡erentiation [28,29].
These lines of evidence raise the possibility that
BMP signals may be maintained at an appropriate
level during chondrogenic di¡erentiation. In ATDC5
cells, the expression of BMP-6 mRNA was di¡eren-
tiation stage-related, and BMP-6 acts as a potent
stimulator of chondrogenic di¡erentiation [21]. We
previously indicated that acquisition of PTH/PTHrP
responsiveness is closely associated with chondrogen-
ic di¡erentiation in ATDC5 cells [22], and that BMP-
6 and PTHrP signals coordinately regulate the rate
of chondrogenic di¡erentiation via downregulation
of the transcript levels of the BMP-6 gene by PTHrP
in these cells [21]. In contrast, both BMP-4 and BMP
type IA receptor in ATDC5 cells are constitutively
expressed during chondrogenic di¡erentiation (data
not shown), and BMP-4 has the same abilities to
stimulate chondrogenic di¡erentiation as BMP-6
[21], suggesting that the amplitude of BMP-4 expres-
sion in ATDC5 cells is regulated during chondrogen-
ic di¡erentiation. Indeed, our recent observations
that BMP-4 and BMP-6 markedly downregulated
the transcript levels of BMP-4 in ATDC5 cells indi-
cate that the stimulatory e¡ects of BMP-4 on chon-
drogenic di¡erentiation in ATDC5 cells are under
the regulatory control by the negative feedback
mechanism [21]. Moreover, in the present study, we
revealed that PTHrP (1^141) transcriptionally down-
Fig. 4. E¡ect of actinomycin D on BMP-4 mRNA decrease by
PTHrP (1^141) in di¡erentiated ATDC5 cells. ATDC5 cells
were cultured on 6-multiwell plastic plates for 21 days. The me-
dium was replaced and cells were cultured in the presence or
absence of actinomycin D (0.2 mM), PTHrP (1^141) (10 nM),
or combinations as indicated. Actinomycin D was added 15
min prior to addition of PTHrP (1^141). Northern analysis was
performed using total RNA (20 Wg per lane) extracted 12 h
after PTHrP (1^141) treatment. Data are shown as the
mean þ S.D. of three separate determinations.
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regulates the expression of BMP-4 mRNA. Our data
thus favor the notion that the stimulatory e¡ects of
BMP-4 on chondrogenic di¡erentiation in ATDC5
cells are under the negative control of both BMPs
and PTHrP signals, which maintained the amplitude
of endogenous BMP-4 signal relatively constant in
both di¡erentiation stage-related and di¡erentiation
stage-unrelated manners.
We next characterized the participation of the in-
tracellular signal transduction pathways of PTHrP
(1^141) in the inhibition of BMP-4 gene expression.
Previous studies indicated that the PTH and PTHrP
signals via PTH/PTHrP common cell surface recep-
tors are transduced by the pathways of PKA and
protein kinase C (PKC) [30^34]. In di¡erentiated
ATDC5 cells, PTHrP (1^141) stimulates both
cAMP accumulation and PKA activity (Table 1)
and direct stimulation of PKA activity by dbcAMP
mimicked the e¡ects of PTHrP (1^141) on the inhi-
bition of BMP-4 gene expression in these cells (Fig.
2). Furthermore, H-89, a PKA inhibitor, blocked the
inhibitory action of BMP-4 gene expression by
PTHrP (1^141). Additionally, PMA, an activator of
PKC, had no signi¢cant e¡ects on BMP-4 gene ex-
pression in ATDC5 cells (data not shown). These
results suggest that the inhibitory action of PTHrP
(1^141) on BMP-4 gene expression is mediated via a
cAMP/PKA signal transduction pathway. Kurihara
et al. [35] and Feng et al. [36] isolated a murine
genomic clone of BMP-4 gene and analyzed the pro-
moter region of this gene. Although cAMP respon-
sive elements cannot be identi¢ed in potential regu-
latory response regions in the 5P-£anking region of
the mouse BMP-4 gene, our observation in the
present study that actinomycin D, a transcriptional
inhibitor, attenuated the inhibitory action of PTHrP
on BMP-4 gene expression suggests that PTHrP
transcriptionally regulates BMP-4 gene expression.
Veri¢cation of the repressor activity of PTHrP (1^
141) and PKA on BMP-4 gene expression needs fur-
ther study.
In conclusion, the amplitude of the BMP-4 signal
in chondrogenic ATDC5 cells may be regulated at an
appropriate level. The transcript level of BMP-4 is
negatively modulated by the PTHrP signal via a
cAMP/PKA pathway.
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